From the Pressroom
News from Kidney Cancer Association This feed has been created by Kidney Cancer Association
Trials Presented at ESMO 2018
on November 14, 2018 at 4:31 pm
In patients with previously untreated advanced renal cell carcinoma (RCC) whose tumors were positive for the PD-L1 checkpoint, a combination of the checkpoint inhibitor avelumab and the tyrosine kinase inhibitor (TKI) axitinib increased the median PFS from 8.4 months to 13.8 months when compared […]
Phase 1 study of everolimus and low-dose oral...
on November 14, 2018 at 4:24 pm
mTOR inhibitors are frequently used in the treatment of metastatic renal cell cancer (mRCC). mTOR regulates cell growth, proliferation, angiogenesis, and survival, and additionally plays an important role in immune regulation. Since mTOR inhibitors were shown to benefit immunosuppressive regulatory […]
CIP2A Promotes Proliferation, Invasion and...
on November 14, 2018 at 4:21 pm
CIP2A is a well-known oncoprotein whose expression is elevated in multiple human solid tumor types. However, its role in renal cell carcinoma (RCC) development is poorly understood.11/14/2018 […]
Submit your press release
We welcome your press releases. The Kidney Cancer Association invites organizations and companies with information of interest to kidney cancer patients, survivors, and their families to submit press releases to:
Fax: +1 (847) 332-2978
Submitters are responsible for the content of press releases and publishing by our charity does not imply the endorsement of the Kidney Cancer Association or its officers, directors, staff, or members.
Events from Kidney Cancer Association This feed has been created by Kidney Cancer Association
Kidney Cancer Support Group - Palo Alto
on December 14, 2018 at 2:00 am
Attend Our Support Group in Palo Alto! Thursday, December 13, 2018 - 6:00pm to 7:30pm Stanford Cancer Center 875 Blake Wilbur Drive Palo Alto, California12/13/2018 06:00 PM - 07:30 PM PTTo register, check the Registration Link […]